Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-05

Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microdevice

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: RECRUITING